These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26789340)

  • 1. INTRAVENOUS CONTRAST IN PATIENTS WITH DIABETES ON METFORMIN: NEW COMMON SENSE GUIDELINES.
    Shah AD; McHargue C; Yee J; Rushakoff RJ
    Endocr Pract; 2016 Apr; 22(4):502-5. PubMed ID: 26789340
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment with metformin in type 2 diabetes mellitus - new routines when renal function is reduced and in connection with administration of iodine contrast media].
    Sterner G; Frid A
    Lakartidningen; 2018 Apr; 115():. PubMed ID: 29634072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast media and metformin: guidelines to diminish the risk of lactic acidosis in non-insulin-dependent diabetics after administration of contrast media. ESUR Contrast Media Safety Committee.
    Thomsen HS; Morcos SK
    Eur Radiol; 1999; 9(4):738-40. PubMed ID: 10354898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention of lactic acidosis due to metformin intoxication in contrast media nephropathy].
    Landewé-Cleuren S; van Zwam WH; de Bruin TW; de Haan M
    Ned Tijdschr Geneeskd; 2000 Sep; 144(40):1903-5. PubMed ID: 11045136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin and contrast media.
    Thomsen HS; Morcos SK; Almén T; Aspelin P; Bellin MF; Clément O; Heinz-Peer G; Reimer P; Stacul F; van der Molen AJ; Webb JA
    Radiology; 2010 Aug; 256(2):672-3; author reply 673. PubMed ID: 20656850
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nephrotoxicity after the use of intravenous X-ray contrast media in a type 2 diabetic being treated with metformin].
    Bjarnason NH; Elung-Jensen T
    Ugeskr Laeger; 2006 May; 168(18):1772-3. PubMed ID: 16729932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metformin and contrast media--increased risk of lactic acidosis?].
    Kløw NE; Draganov B; Os I
    Tidsskr Nor Laegeforen; 2001 Jun; 121(15):1829. PubMed ID: 11464691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lactic acidosis feared adverse effect of metformin treatment. New guidelines can increase vigilance].
    Berne C; Hietala SO
    Lakartidningen; 1999 Dec; 96(50):5598-9. PubMed ID: 10643216
    [No Abstract]   [Full Text] [Related]  

  • 9. Metformin and contrast media--a dangerous combination?
    McCartney MM; Gilbert FJ; Murchison LE; Pearson D; McHardy K; Murray AD
    Clin Radiol; 1999 Jan; 54(1):29-33. PubMed ID: 9915507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Proposal for the modification of metformin use in patients with chronic kidney disease].
    Balogh Z; Mátyus J
    Orv Hetil; 2012 Sep; 153(39):1527-35. PubMed ID: 23000419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin: preventable lactic acidosis.
    Prescrire Int; 2007 Feb; 16(87):19. PubMed ID: 17323526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin, contrast media, and theophylline.
    Quasny H
    Am J Health Syst Pharm; 1997 Sep; 54(17):2007-8. PubMed ID: 9290904
    [No Abstract]   [Full Text] [Related]  

  • 13. Theophylline option for attenuating contrast media-induced nephrotoxicity in patients on metformin.
    Nolan DB
    Am J Health Syst Pharm; 1997 Mar; 54(5):587-8. PubMed ID: 9066873
    [No Abstract]   [Full Text] [Related]  

  • 14. Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin.
    Goergen SK; Rumbold G; Compton G; Harris C
    Radiology; 2010 Jan; 254(1):261-9. PubMed ID: 20032157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A justification for less restrictive guidelines on the use of metformin in stable chronic renal failure.
    Adam WR; O'Brien RC
    Diabet Med; 2014 Sep; 31(9):1032-8. PubMed ID: 24909998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New contraindication to intravascular iodinated contrast material.
    Dachman AH
    Radiology; 1995 Nov; 197(2):545. PubMed ID: 7480710
    [No Abstract]   [Full Text] [Related]  

  • 17. Metformin-induced lactic acidosis associated with acute renal failure.
    Safadi R; Dranitzki-Elhalel M; Popovtzer M; Ben-Yehuda A
    Am J Nephrol; 1996; 16(6):520-2. PubMed ID: 8955764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limitations of metformin use in patients with kidney disease: are they warranted?
    Vasisht KP; Chen SC; Peng Y; Bakris GL
    Diabetes Obes Metab; 2010 Dec; 12(12):1079-83. PubMed ID: 20977579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The art and science of medical guidelines: what we know and what we believe.
    Brink JA
    Radiology; 2010 Jan; 254(1):20-1. PubMed ID: 20032138
    [No Abstract]   [Full Text] [Related]  

  • 20. [Metformin Therapy During Surgical Interventions and Iodinated Contrast Agent Use].
    Masur S; Eisert A; Freitag M
    Dtsch Med Wochenschr; 2021 Jan; 146(2):121-127. PubMed ID: 33465808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.